Novo Nordisk
NVO
$146.69
Share price
-0.41%
Change (1 day)
33.12%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Operating Margin for Novo Nordisk (NVO)
Operating Margin as of March 2023 (TTM): 41.96%
According to Novo Nordisk's latest financial reports and stock price the company's current Operating Margin is 41.96%. At the end of 2021 the company had an Operating Margin of 41.96%.
Operating Margin history for Novo Nordisk from 2004 to 2003
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 41.96% | 0.26% |
| 2020 | 41.85% | 5.18% |
| 2019 | 39.79% | -6.55% |
| 2018 | 42.58% | -2.31% |
| 2017 | 43.58% | 1.92% |
| 2016 | 42.76% | 6.13% |
| 2015 | 40.29% | 4.94% |
| 2014 | 38.39% | -1.39% |
| 2013 | 38.94% | 9.24% |
| 2012 | 35.64% | 7.86% |
| 2011 | 33.05% | 9.83% |
| 2010 | 30.09% | 9.87% |
| 2009 | 27.39% | -1.73% |
| 2008 | 27.87% | 6.27% |
| 2007 | 26.22% | 10.88% |
| 2006 | 23.65% | -3% |
| 2005 | 24.38% | -5.05% |
| 2004 | 25.68% | -9.84% |
| 2003 | 28.48% | 13.87% |
| 2002 | 25.01% | -1.37% |
| 2001 | 25.36% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 29.90% | -28.74% | 🇺🇸 USA |
 Eli Lilly LLY | 23.84% | -43.18% | 🇺🇸 USA |
 Sanofi SNY | 19.90% | -52.57% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | 16.70% | -60.20% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.